nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCB1—peripheral nervous system neoplasm	0.297	1	CbGaD
Apixaban—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0701	0.119	CbGbCtD
Apixaban—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0486	0.0825	CbGbCtD
Apixaban—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0361	0.0613	CbGbCtD
Apixaban—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0347	0.059	CbGbCtD
Apixaban—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0299	0.0508	CbGbCtD
Apixaban—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0289	0.0491	CbGbCtD
Apixaban—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0279	0.0474	CbGbCtD
Apixaban—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0274	0.0466	CbGbCtD
Apixaban—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0253	0.0429	CbGbCtD
Apixaban—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0253	0.0429	CbGbCtD
Apixaban—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0411	CbGbCtD
Apixaban—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0231	0.0393	CbGbCtD
Apixaban—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0187	0.0318	CbGbCtD
Apixaban—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0175	0.0298	CbGbCtD
Apixaban—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0166	0.0282	CbGbCtD
Apixaban—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0152	0.0258	CbGbCtD
Apixaban—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0151	0.0257	CbGbCtD
Apixaban—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0146	0.0248	CbGbCtD
Apixaban—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0141	0.0239	CbGbCtD
Apixaban—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0113	0.0192	CbGbCtD
Apixaban—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0108	0.0183	CbGbCtD
Apixaban—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0104	0.0176	CbGbCtD
Apixaban—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0101	0.0171	CbGbCtD
Apixaban—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00988	0.0168	CbGbCtD
Apixaban—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00674	0.0115	CbGbCtD
Apixaban—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00646	0.011	CbGbCtD
Apixaban—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00592	0.0101	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00404	0.00686	CbGbCtD
Apixaban—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000446	0.0039	CcSEcCtD
Apixaban—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.000443	0.00387	CcSEcCtD
Apixaban—Urinary tract disorder—Isotretinoin—peripheral nervous system neoplasm	0.000441	0.00385	CcSEcCtD
Apixaban—Urinary tract disorder—Tretinoin—peripheral nervous system neoplasm	0.000441	0.00385	CcSEcCtD
Apixaban—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.000441	0.00385	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Etoposide—peripheral nervous system neoplasm	0.000439	0.00383	CcSEcCtD
Apixaban—Urethral disorder—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00382	CcSEcCtD
Apixaban—Urethral disorder—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00382	CcSEcCtD
Apixaban—Urinary tract disorder—Melphalan—peripheral nervous system neoplasm	0.000435	0.0038	CcSEcCtD
Apixaban—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.000433	0.00378	CcSEcCtD
Apixaban—Urethral disorder—Melphalan—peripheral nervous system neoplasm	0.000432	0.00377	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Vincristine—peripheral nervous system neoplasm	0.000424	0.0037	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—peripheral nervous system neoplasm	0.000424	0.0037	CcSEcCtD
Apixaban—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.000417	0.00364	CcSEcCtD
Apixaban—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.000417	0.00364	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.000417	0.00364	CcSEcCtD
Apixaban—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.000408	0.00356	CcSEcCtD
Apixaban—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000406	0.00355	CcSEcCtD
Apixaban—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.000406	0.00354	CcSEcCtD
Apixaban—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.000405	0.00354	CcSEcCtD
Apixaban—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.000405	0.00354	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00348	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00348	CcSEcCtD
Apixaban—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000398	0.00347	CcSEcCtD
Apixaban—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.000397	0.00347	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.00343	CcSEcCtD
Apixaban—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.000376	0.00329	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.000375	0.00328	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00322	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00322	CcSEcCtD
Apixaban—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000362	0.00316	CcSEcCtD
Apixaban—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00314	CcSEcCtD
Apixaban—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000359	0.00314	CcSEcCtD
Apixaban—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000359	0.00314	CcSEcCtD
Apixaban—Petechiae—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00313	CcSEcCtD
Apixaban—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.000355	0.0031	CcSEcCtD
Apixaban—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000354	0.00309	CcSEcCtD
Apixaban—Syncope—Tretinoin—peripheral nervous system neoplasm	0.000348	0.00304	CcSEcCtD
Apixaban—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.000348	0.00304	CcSEcCtD
Apixaban—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.000342	0.00298	CcSEcCtD
Apixaban—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.000342	0.00298	CcSEcCtD
Apixaban—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.00297	CcSEcCtD
Apixaban—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.00295	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.000337	0.00294	CcSEcCtD
Apixaban—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00292	CcSEcCtD
Apixaban—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00289	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.00289	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000331	0.00289	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000329	0.00287	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000329	0.00287	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00285	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000324	0.00283	CcSEcCtD
Apixaban—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.000322	0.00281	CcSEcCtD
Apixaban—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00032	0.0028	CcSEcCtD
Apixaban—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00032	0.00279	CcSEcCtD
Apixaban—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.00032	0.00279	CcSEcCtD
Apixaban—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00277	CcSEcCtD
Apixaban—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00277	CcSEcCtD
Apixaban—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00276	CcSEcCtD
Apixaban—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000313	0.00274	CcSEcCtD
Apixaban—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000313	0.00273	CcSEcCtD
Apixaban—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000313	0.00273	CcSEcCtD
Apixaban—Shock—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00272	CcSEcCtD
Apixaban—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00272	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—peripheral nervous system neoplasm	0.000312	0.00272	CcSEcCtD
Apixaban—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00272	CcSEcCtD
Apixaban—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00272	CcSEcCtD
Apixaban—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000311	0.00271	CcSEcCtD
Apixaban—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00031	0.00271	CcSEcCtD
Apixaban—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00031	0.00271	CcSEcCtD
Apixaban—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000308	0.00269	CcSEcCtD
Apixaban—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000308	0.00269	CcSEcCtD
Apixaban—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00268	CcSEcCtD
Apixaban—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000306	0.00268	CcSEcCtD
Apixaban—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000304	0.00265	CcSEcCtD
Apixaban—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00265	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.00264	CcSEcCtD
Apixaban—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000296	0.00259	CcSEcCtD
Apixaban—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.00259	CcSEcCtD
Apixaban—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000296	0.00258	CcSEcCtD
Apixaban—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000294	0.00256	CcSEcCtD
Apixaban—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000294	0.00256	CcSEcCtD
Apixaban—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000292	0.00255	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00252	CcSEcCtD
Apixaban—Melaena—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00251	CcSEcCtD
Apixaban—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000285	0.00248	CcSEcCtD
Apixaban—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00247	CcSEcCtD
Apixaban—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00247	CcSEcCtD
Apixaban—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000278	0.00243	CcSEcCtD
Apixaban—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000276	0.00241	CcSEcCtD
Apixaban—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000274	0.00239	CcSEcCtD
Apixaban—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000274	0.00239	CcSEcCtD
Apixaban—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00238	CcSEcCtD
Apixaban—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00027	0.00236	CcSEcCtD
Apixaban—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00235	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00233	CcSEcCtD
Apixaban—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00233	CcSEcCtD
Apixaban—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00231	CcSEcCtD
Apixaban—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000262	0.00229	CcSEcCtD
Apixaban—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000261	0.00228	CcSEcCtD
Apixaban—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00227	CcSEcCtD
Apixaban—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00227	CcSEcCtD
Apixaban—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000259	0.00226	CcSEcCtD
Apixaban—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00226	CcSEcCtD
Apixaban—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000254	0.00222	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.00217	CcSEcCtD
Apixaban—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000247	0.00215	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.00215	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00215	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00215	CcSEcCtD
Apixaban—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.0021	CcSEcCtD
Apixaban—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00024	0.00209	CcSEcCtD
Apixaban—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000239	0.00208	CcSEcCtD
Apixaban—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000238	0.00208	CcSEcCtD
Apixaban—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00206	CcSEcCtD
Apixaban—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00206	CcSEcCtD
Apixaban—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000236	0.00206	CcSEcCtD
Apixaban—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00205	CcSEcCtD
Apixaban—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000234	0.00204	CcSEcCtD
Apixaban—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000234	0.00204	CcSEcCtD
Apixaban—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00204	CcSEcCtD
Apixaban—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000232	0.00202	CcSEcCtD
Apixaban—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000232	0.00202	CcSEcCtD
Apixaban—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000231	0.00201	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00199	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00199	CcSEcCtD
Apixaban—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000227	0.00198	CcSEcCtD
Apixaban—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000227	0.00198	CcSEcCtD
Apixaban—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00196	CcSEcCtD
Apixaban—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000216	0.00189	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00187	CcSEcCtD
Apixaban—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000212	0.00185	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000212	0.00185	CcSEcCtD
Apixaban—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000211	0.00185	CcSEcCtD
Apixaban—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00021	0.00183	CcSEcCtD
Apixaban—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.00183	CcSEcCtD
Apixaban—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.00181	CcSEcCtD
Apixaban—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00179	CcSEcCtD
Apixaban—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000202	0.00176	CcSEcCtD
Apixaban—Rash—Topotecan—peripheral nervous system neoplasm	0.000202	0.00176	CcSEcCtD
Apixaban—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000201	0.00176	CcSEcCtD
Apixaban—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00175	CcSEcCtD
Apixaban—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00175	CcSEcCtD
Apixaban—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.00175	CcSEcCtD
Apixaban—Rash—Tretinoin—peripheral nervous system neoplasm	0.0002	0.00175	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.0002	0.00175	CcSEcCtD
Apixaban—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.00174	CcSEcCtD
Apixaban—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0002	0.00174	CcSEcCtD
Apixaban—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000199	0.00174	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00173	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00172	CcSEcCtD
Apixaban—Rash—Melphalan—peripheral nervous system neoplasm	0.000197	0.00172	CcSEcCtD
Apixaban—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000197	0.00172	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000194	0.0017	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00169	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00168	CcSEcCtD
Apixaban—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00167	CcSEcCtD
Apixaban—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.00167	CcSEcCtD
Apixaban—Nausea—Topotecan—peripheral nervous system neoplasm	0.00019	0.00166	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00165	CcSEcCtD
Apixaban—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00164	CcSEcCtD
Apixaban—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00164	CcSEcCtD
Apixaban—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000188	0.00164	CcSEcCtD
Apixaban—Nausea—Melphalan—peripheral nervous system neoplasm	0.000186	0.00162	CcSEcCtD
Apixaban—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000184	0.0016	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.0016	CcSEcCtD
Apixaban—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000182	0.00159	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00156	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.00156	CcSEcCtD
Apixaban—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.00155	CcSEcCtD
Apixaban—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000177	0.00154	CcSEcCtD
Apixaban—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000175	0.00153	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00152	CcSEcCtD
Apixaban—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000171	0.00149	CcSEcCtD
Apixaban—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.00143	CcSEcCtD
Apixaban—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000162	0.00141	CcSEcCtD
Apixaban—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00139	CcSEcCtD
Apixaban—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00137	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00136	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00136	CcSEcCtD
Apixaban—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.00134	CcSEcCtD
Apixaban—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000153	0.00134	CcSEcCtD
Apixaban—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00132	CcSEcCtD
Apixaban—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00132	CcSEcCtD
Apixaban—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000151	0.00132	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000149	0.0013	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00129	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00128	CcSEcCtD
Apixaban—Rash—Vincristine—peripheral nervous system neoplasm	0.000146	0.00127	CcSEcCtD
Apixaban—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000146	0.00127	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00127	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00127	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00127	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00126	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00126	CcSEcCtD
Apixaban—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.00125	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00121	CcSEcCtD
Apixaban—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000138	0.00121	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.0012	CcSEcCtD
Apixaban—Nausea—Vincristine—peripheral nervous system neoplasm	0.000138	0.0012	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.0012	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00118	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00117	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00117	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00117	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00117	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00116	CcSEcCtD
Apixaban—Rash—Cisplatin—peripheral nervous system neoplasm	0.000129	0.00113	CcSEcCtD
Apixaban—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000129	0.00113	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00112	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00108	CcSEcCtD
Apixaban—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000124	0.00108	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00108	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00108	CcSEcCtD
Apixaban—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000122	0.00106	CcSEcCtD
Apixaban—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00104	CcSEcCtD
Apixaban—Rash—Etoposide—peripheral nervous system neoplasm	0.000118	0.00103	CcSEcCtD
Apixaban—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000118	0.00103	CcSEcCtD
Apixaban—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00101	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000989	CcSEcCtD
Apixaban—Nausea—Etoposide—peripheral nervous system neoplasm	0.000111	0.000973	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000962	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000951	CcSEcCtD
Apixaban—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000933	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000918	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000915	CcSEcCtD
Apixaban—Shock—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000903	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0009	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000899	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000892	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00088	CcSEcCtD
Apixaban—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000858	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000849	CcSEcCtD
Apixaban—Shock—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000836	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000833	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000832	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000825	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000794	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000793	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000733	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000676	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000626	CcSEcCtD
Apixaban—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000607	CcSEcCtD
Apixaban—Rash—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000579	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000578	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000562	CcSEcCtD
Apixaban—Nausea—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000545	CcSEcCtD
Apixaban—Rash—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000536	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000535	CcSEcCtD
Apixaban—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000505	CcSEcCtD
